InvestorsHub Logo
icon url

nobrainerstocks

04/08/17 12:01 PM

#100116 RE: XenaLives #100112

A little more on Harald Hampel

Harald Hampel has, during the past years, received lecture honoraria and/or research grants and/or travel funding and/or participated in scientific advisory boards and/or served as a consultant to diagnostic, biotechnology and pharmaceutical companies involved in the manufacture and marketing of biomarkers and/or diagnostics and/or drugs or medicinal products for cognitive impairment and/or Alzheimer's disease. These companies include Boehringer-Ingelheim, Bristol-Myers Squibb, Elan Corporation, Wyeth, Novartis, Eisai, Pfizer, Schwabe, Sanofi-Aventis, Roche Pharmaceuticals and Diagnostics, GE Healthcare, Astra-Zeneca, Avid, Eli Lilly and Company, Janssen-Cilag, Merz Pharmaceuticals, GlaxoSmithKline-Biologicals, Jung-Diagnostics and Thermo Fisher Scientific Clinical Diagnostics. He is co-inventor in pending patent submissions relating to biological markers and/or diagnostics.

Is that enough expertise for you Amatuer?